The MedTech sector is experiencing a dynamic shift as mergers and acquisitions (M&A) continue to reshape the industry. With evolving technological advancements, regulatory updates, and shifting market priorities, companies are leveraging strategic acquisitions to drive growth and maintain competitive advantages. Understanding these factors is essential for MedTech leaders aiming to capitalize on emerging opportunities in 2024 and beyond.

As the EU charges ahead with its ambitious renewable energy targets under the REPowerEU plan, the challenge lies in turning large-scale goals into actionable solutions. Decentralized energy production through home solar panels and heat pumps is a step forward, but the question of financing remains critical. While the U.S. has seen success with solar securitization, Europe faces unique hurdles, from fragmented regulation to consumer diversity. Yet, innovative structured credit solutions offer a tailored path forward, enabling businesses to scale sustainably and unlock new opportunities in green energy financing. Discover how Alvarez & Marsal can guide you through this evolving landscape.

According to the Institute of Public Policy Research, presenteeism, or working whilst sick, cost the UK economy £25bn in 2023, whilst absenteeism cost an additional £5bn. To address these challenges, many workplaces now emphasise proactive, value-added services for employee wellbeing and performance, delivered both on-site and online. This shift has spurred growth in the Occupational Health market, attracting significant interest from financial investors and strategic acquirers.

London, 4 November 2024 – Leading global professional services firm Alvarez & Marsal (A&M) continues to strengthen its Corporate Finance practice in the UK with the appointment of Ian Birch as a Managing Director in Birmingham. At A&M, he will build out the practice’s technology M&A capability across Europe.